Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The University of California San Francisco (UCSF) is developing a new center dedicated to applying AI to the field of radiology and improving patient outcomes.
Machine learning (ML) algorithms could potentially be trained to alter mammography findings, tricking radiologists into make an incorrect diagnosis, according to new research published in the European Journal of Radiology.
The British Heart Foundation (BHF) has awarded researchers at University College London (UCL) £1 million ($1.27 million) to study cardiovascular disease. The funding will be used to bring in a new team of researchers and develop a research center focused on AI.
Sensyne Health announced Thursday, Oct. 10, that it has joined Bayer’s newest innovation hub, LifeHub UK, and will work toward developing solutions for automated image evaluation.
A team of researchers from West Virginia and Arkansas are beginning a four-year project aimed at using AI to improve the treatment of cardiovascular disease and cut healthcare costs.
AI can improve CT findings and play a key role in the evaluation of hypovascular hepatic metastases, according to a new study published in Radiology: Artificial Intelligence.
Insilico Medicine, a Hong Kong-based AI company, has announced a new collaboration with Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. (CTFH) aimed at improving care for breast cancer patients.
